Cargando…

A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of Leishmania donovani

The huge burden of leishmaniasis caused by the trypanosomatid protozoan parasite Leishmania is well known. This illness was included in the list of neglected tropical diseases targeted for elimination by the World Health Organization. However, the increasing evidence of resistance to existing antimo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broni, Emmanuel, Kwofie, Samuel K., Asiedu, Seth O., Miller, Whelton A., Wilson, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003136/ https://www.ncbi.nlm.nih.gov/pubmed/33803906 http://dx.doi.org/10.3390/biom11030458

Ejemplares similares

Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling
por: Sakyi, Patrick O., et al.
Publicado: (2023)

Homology Modeling, de Novo Design of Ligands, and Molecular Docking Identify Potential Inhibitors of Leishmania donovani 24-Sterol Methyltransferase
por: Sakyi, Patrick O., et al.
Publicado: (2022)

Some novel antileishmanial compounds inhibit normal cell cycle progression of Leishmania donovani promastigotes and exhibits pro-oxidative potential
por: Amlabu, Wandayi Emmanuel, et al.
Publicado: (2021)

Identification of Inhibitors of the Leishmania cdc2-Related Protein Kinase CRK3
por: Cleghorn, Laura A T, et al.
Publicado: (2011)

Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm
por: Asiedu, Seth O., et al.
Publicado: (2021)

Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs
por: Rastrojo, Alberto, et al.
Publicado: (2018)

Enhanced Glycolysis Is Required for Antileishmanial Functions of Neutrophils Upon Infection With Leishmania donovani
por: Ohms, Mareike, et al.
Publicado: (2021)

Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo
por: Afrin, Farhat, et al.
Publicado: (2019)

Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against Leishmania donovani
por: Cabral, Lília I. L., et al.
Publicado: (2020)

Leishmania donovani Impedes Antileishmanial Immunity by Suppressing Dendritic Cells via the TIM-3 Receptor
por: Akhtar, Md. Naushad, et al.
Publicado: (2022)

The triterpenoid fraction from Trichosanthes dioica root exhibits in vitro antileishmanial effect against Leishmania donovani promastigotes
por: Bhattacharya, Sanjib, et al.
Publicado: (2013)

Oxidative Stress-Mediated Overexpression of Uracil DNA Glycosylase in Leishmania donovani Confers Tolerance against Antileishmanial Drugs
por: Mishra, Anshul, et al.
Publicado: (2018)

Cynaroside inhibits Leishmania donovani UDP-galactopyranose mutase and induces reactive oxygen species to exert antileishmanial response
por: Tabrez, Shams, et al.
Publicado: (2021)

Profilin is involved in G1 to S phase progression and mitotic spindle orientation during Leishmania donovani cell division cycle
por: Ambaru, Bindu, et al.
Publicado: (2022)

Molecular Docking Simulation Studies Identifies Potential Natural Product Derived-Antiwolbachial Compounds as Filaricides against Onchocerciasis
por: Kwofie, Samuel K., et al.
Publicado: (2021)

Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin
por: Kwofie, Samuel K., et al.
Publicado: (2021)

Genomic and Phenotypic Characterization of Experimentally Selected Resistant Leishmania donovani Reveals a Role for Dynamin-1-Like Protein in the Mechanism of Resistance to a Novel Antileishmanial Compound
por: Hefnawy, Aya, et al.
Publicado: (2022)

In vitro activity and mode of action of phenolic compounds on Leishmania donovani
por: Antwi, Christine Achiaa, et al.
Publicado: (2019)

Imidazo[1,2-a]pyrimidine as a New Antileishmanial Pharmacophore against Leishmania amazonensis Promastigotes and Amastigotes
por: Kumar, Ravinder, et al.
Publicado: (2023)

Elucidating the possible mechanism of action of some pathogen box compounds against Leishmania donovani
por: Amlabu, Wandayi Emmanuel, et al.
Publicado: (2020)

LEISHMANIA DONOVANI IN THE PERIPHERAL BLOOD
por: Young, Charles W., et al.
Publicado: (1923)

Casein kinase 1.2 over expression restores stress resistance to Leishmania donovani HSP23 null mutants
por: Kröber-Boncardo, Constanze, et al.
Publicado: (2020)

Bioassay-based Corchorus capsularis L. leaf-derived β-sitosterol exerts antileishmanial effects against Leishmania donovani by targeting trypanothione reductase
por: Pramanik, Pijush Kanti, et al.
Publicado: (2020)

CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azoles
por: Jin, Yiru, et al.
Publicado: (2023)

Antileishmanial effects of γCdcPLI, a phospholipase A(2) inhibitor from Crotalus durissus collilineatus snake serum, on Leishmania (Leishmania) amazonensis
por: Gonçalves, Marina Neves, et al.
Publicado: (2023)

Unveiling the Kinomes of Leishmania infantum and L. braziliensis Empowers the Discovery of New Kinase Targets and Antileishmanial Compounds
por: Borba, Joyce V.B., et al.
Publicado: (2019)

Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB
por: Pérez-Pertejo, Yolanda, et al.
Publicado: (2019)

Proteomic analysis of the secretome of Leishmania donovani
por: Silverman, J Maxwell, et al.
Publicado: (2008)

Surface antigens of Leishmania donovani promastigotes
Publicado: (1983)

Vaccine Development Against Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2012)

Leishmania donovani bodies in bone marrow
por: Ali, Natasha, et al.
Publicado: (2014)

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
por: Jain, Surendra K., et al.
Publicado: (2012)

In-vitro and In-vivo Antileishmanial Activity of a Compound Derived of Platinum, Oxaliplatin, against Leishmania Major
por: Ghasemi, Ezatollah, et al.
Publicado: (2019)

Life Cycle Stage-Specific Accessibility of Leishmania donovani Chromatin at Transcription Start Regions
por: Grünebast, Janne, et al.
Publicado: (2021)

Antifungal compounds from Streptomyces associated with attine ants also inhibit Leishmania donovani
por: Ortega, Humberto E., et al.
Publicado: (2019)

Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
por: Tadele, Markos, et al.
Publicado: (2020)

The identification of kala-azar and the discovery of Leishmania donovani.
por: Gibson, M E
Publicado: (1983)

Leishmania donovani and Cutaneous Leishmaniasis, Sri Lanka
por: Siriwardana, H. V. Yamuna D., et al.
Publicado: (2007)

Leishmania donovani Develops Resistance to Drug Combinations
por: García-Hernández, Raquel, et al.
Publicado: (2012)

Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani
por: Morimoto, Ayako, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7jfs1fsd541nqp0sj19v9drj20